40032-090-19 |
40032-090 |
HUMAN PRESCRIPTION DRUG |
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES |
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES |
POWDER, FOR SOLUTION |
ORAL |
20090601 |
N/A |
ANDA |
ANDA090231 |
Novel Laboratories, Inc. |
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
236 g/274.31g; 2.97 g/274.31g; 6.74 g/274.31g; 5.86 g/274.31g; 22.74 g/274.31g |
274.31 g in 1 BOTTLE (40032-090-19) |
43386-090-19 |
43386-090 |
HUMAN PRESCRIPTION DRUG |
GAVILYTE G TM |
polyethylene glycol-3350 and Electrolytes |
POWDER, FOR SOLUTION |
ORAL |
20090601 |
N/A |
ANDA |
ANDA090231 |
Lupin Pharmaceuticals,Inc. |
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
236 g/274.31g; 2.97 g/274.31g; 6.74 g/274.31g; 5.86 g/274.31g; 22.74 g/274.31g |
274.31 g in 1 BOTTLE (43386-090-19) |